{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-2520"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-2520","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Characterization and regulation of Skn-directed autoimmune skin lesions","abstract":"In the Skn model of autoimmunity, pathogenic T cells sensitized to Skn epidermal antigens (Skn-immune spleen cells or SIS cells) elicited disease in the form of skin lesions when adoptively transferred into shaved immunoincompetent syngeneic adult recipients (‘lesion-forming animals’) while concomitant injection of immunoregulatory normal spleen cells at twice the concentration (2 x normal spleen cells or 2XNS cells) of SIS cells significantly lessened lesion development (‘lesion-controlling animals’) by Day 7 post cell transfer. In a time-course RT-PCR cytokine analysis of skin from lesion-forming and lesion-controlling animals, IL-7 mRNA was significantly elevated in lesion-controlling skin on Day 7 while no significant differences were observed for IL-2, IL-4, IL-10, IL-12, IFN-γ or TGF-β. The CD4+ T cell was identified as the immunoregulatory cells within the normal spleen cell population which, when adoptively transferred, significantly reduced lesion grade by Day 7 and were also associated with an elevated IL-7 mRNA level in the skin. To determine whether, IL-7 was exogenously expressed in the skin of lesion-forming animals using a topically-applied plasmid-IL-7 somatic gene therapy. Daily application of plasmid-IL-7 facilitated by brushing at sites that flanked the known reactive site for lesion development significantly reduced lesion severity which was observed to be comparable to that observed with cotransfer of 2XNS or CD4-enriched normal spleen cells. The absence of endogenous IL-7 mRNA in lesion-controlling plasmid-IL-7 recipients indicated that plasmid-IL-7 mediated lesion control independently of endogenous IL-7. Exogenous-IL-7 mRNA expression in the skin was associated with a downregulated expression of endogenous IL-7 messages suggesting that an IL-7 homeostatic mechanism existed in the skin responsive to plasmid-IL-7 therapy. Furthermore, plasmid-IL-7 mRNA expression in the skin did not appear to disrupt the cytokine milieu of the skin or to work in concert with other cytokines analyzed. While others have reported a regulatory role for CD4+ T cells, this represents the first report of a topically applied somatic gene delivery of IL-7 in the skin of mice resulting in the control of autoimmune skin lesions.","abstract_html":"In the Skn model of autoimmunity, pathogenic T cells sensitized to Skn epidermal antigens (Skn-immune spleen cells or SIS cells) elicited disease in the form of skin lesions when adoptively transferred into shaved immunoincompetent syngeneic adult recipients (‘lesion-forming animals’) while concomitant injection of immunoregulatory normal spleen cells at twice the concentration (2 x normal spleen cells or 2XNS cells) of SIS cells significantly lessened lesion development (‘lesion-controlling animals’) by Day 7 post cell transfer. In a time-course RT-PCR cytokine analysis of skin from lesion-forming and lesion-controlling animals, IL-7 mRNA was significantly elevated in lesion-controlling skin on Day 7 while no significant differences were observed for IL-2, IL-4, IL-10, IL-12, IFN-γ or TGF-β. The CD4+ T cell was identified as the immunoregulatory cells within the normal spleen cell population which, when adoptively transferred, significantly reduced lesion grade by Day 7 and were also associated with an elevated IL-7 mRNA level in the skin. To determine whether, IL-7 was exogenously expressed in the skin of lesion-forming animals using a topically-applied plasmid-IL-7 somatic gene therapy. Daily application of plasmid-IL-7 facilitated by brushing at sites that flanked the known reactive site for lesion development significantly reduced lesion severity which was observed to be comparable to that observed with cotransfer of 2XNS or CD4-enriched normal spleen cells. The absence of endogenous IL-7 mRNA in lesion-controlling plasmid-IL-7 recipients indicated that plasmid-IL-7 mediated lesion control independently of endogenous IL-7. Exogenous-IL-7 mRNA expression in the skin was associated with a downregulated expression of endogenous IL-7 messages suggesting that an IL-7 homeostatic mechanism existed in the skin responsive to plasmid-IL-7 therapy. Furthermore, plasmid-IL-7 mRNA expression in the skin did not appear to disrupt the cytokine milieu of the skin or to work in concert with other cytokines analyzed. While others have reported a regulatory role for CD4+ T cells, this represents the first report of a topically applied somatic gene delivery of IL-7 in the skin of mice resulting in the control of autoimmune skin lesions.","abstract_has_math":false,"creators":["Staton, Pamela Jane"],"institution":null,"degree_name":"Biomedical Sciences","degree_level":"Dissertation","degree_discipline":"Joan C. Edwards School of Medicine","degree_department":null,"school":null,"contributors":["Donald Primerano","Elizabeth Bryda","Vernon Reichenbecher"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:57:29Z","subjects":["Biochemistry, Biophysics, and Structural Biology","Biology","Cell and Developmental Biology","Cell Biology","Life Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/1515","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/1515","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-2520","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Donald Primerano","Elizabeth Bryda","Vernon Reichenbecher"]},{"key":"dc:creator","label":"Author","values":["Staton, Pamela Jane"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2022-07-28T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2001-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Joan C. Edwards School of Medicine"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Biomedical Sciences"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biochemistry, Biophysics, and Structural Biology","Biology","Cell and Developmental Biology","Cell Biology","Life Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/1515"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["In the Skn model of autoimmunity, pathogenic T cells sensitized to Skn epidermal antigens (Skn-immune spleen cells or SIS cells) elicited disease in the form of skin lesions when adoptively transferred into shaved immunoincompetent syngeneic adult recipients (‘lesion-forming animals’) while concomitant injection of immunoregulatory normal spleen cells at twice the concentration (2 x normal spleen cells or 2XNS cells) of SIS cells significantly lessened lesion development (‘lesion-controlling animals’) by Day 7 post cell transfer. In a time-course RT-PCR cytokine analysis of skin from lesion-forming and lesion-controlling animals, IL-7 mRNA was significantly elevated in lesion-controlling skin on Day 7 while no significant differences were observed for IL-2, IL-4, IL-10, IL-12, IFN-γ or TGF-β. The CD4+ T cell was identified as the immunoregulatory cells within the normal spleen cell population which, when adoptively transferred, significantly reduced lesion grade by Day 7 and were also associated with an elevated IL-7 mRNA level in the skin. To determine whether, IL-7 was exogenously expressed in the skin of lesion-forming animals using a topically-applied plasmid-IL-7 somatic gene therapy. Daily application of plasmid-IL-7 facilitated by brushing at sites that flanked the known reactive site for lesion development significantly reduced lesion severity which was observed to be comparable to that observed with cotransfer of 2XNS or CD4-enriched normal spleen cells. The absence of endogenous IL-7 mRNA in lesion-controlling plasmid-IL-7 recipients indicated that plasmid-IL-7 mediated lesion control independently of endogenous IL-7. Exogenous-IL-7 mRNA expression in the skin was associated with a downregulated expression of endogenous IL-7 messages suggesting that an IL-7 homeostatic mechanism existed in the skin responsive to plasmid-IL-7 therapy. Furthermore, plasmid-IL-7 mRNA expression in the skin did not appear to disrupt the cytokine milieu of the skin or to work in concert with other cytokines analyzed. While others have reported a regulatory role for CD4+ T cells, this represents the first report of a topically applied somatic gene delivery of IL-7 in the skin of mice resulting in the control of autoimmune skin lesions."]},{"key":"dc:title","label":"Title","values":["Characterization and regulation of Skn-directed autoimmune skin lesions"]}]}],"canonical_facts":{"dc:contributor":["Donald Primerano","Elizabeth Bryda","Vernon Reichenbecher"],"dc:creator":["Staton, Pamela Jane"],"dc:date.available":["2022-07-28T07:00:00Z"],"dc:date.created":["2001-01-01T08:00:00Z"],"dc:description.abstract":["In the Skn model of autoimmunity, pathogenic T cells sensitized to Skn epidermal antigens (Skn-immune spleen cells or SIS cells) elicited disease in the form of skin lesions when adoptively transferred into shaved immunoincompetent syngeneic adult recipients (‘lesion-forming animals’) while concomitant injection of immunoregulatory normal spleen cells at twice the concentration (2 x normal spleen cells or 2XNS cells) of SIS cells significantly lessened lesion development (‘lesion-controlling animals’) by Day 7 post cell transfer. In a time-course RT-PCR cytokine analysis of skin from lesion-forming and lesion-controlling animals, IL-7 mRNA was significantly elevated in lesion-controlling skin on Day 7 while no significant differences were observed for IL-2, IL-4, IL-10, IL-12, IFN-γ or TGF-β. The CD4+ T cell was identified as the immunoregulatory cells within the normal spleen cell population which, when adoptively transferred, significantly reduced lesion grade by Day 7 and were also associated with an elevated IL-7 mRNA level in the skin. To determine whether, IL-7 was exogenously expressed in the skin of lesion-forming animals using a topically-applied plasmid-IL-7 somatic gene therapy. Daily application of plasmid-IL-7 facilitated by brushing at sites that flanked the known reactive site for lesion development significantly reduced lesion severity which was observed to be comparable to that observed with cotransfer of 2XNS or CD4-enriched normal spleen cells. The absence of endogenous IL-7 mRNA in lesion-controlling plasmid-IL-7 recipients indicated that plasmid-IL-7 mediated lesion control independently of endogenous IL-7. Exogenous-IL-7 mRNA expression in the skin was associated with a downregulated expression of endogenous IL-7 messages suggesting that an IL-7 homeostatic mechanism existed in the skin responsive to plasmid-IL-7 therapy. Furthermore, plasmid-IL-7 mRNA expression in the skin did not appear to disrupt the cytokine milieu of the skin or to work in concert with other cytokines analyzed. While others have reported a regulatory role for CD4+ T cells, this represents the first report of a topically applied somatic gene delivery of IL-7 in the skin of mice resulting in the control of autoimmune skin lesions."],"dc:identifier":["https://mds.marshall.edu/etd/1515"],"dc:subject":["Biochemistry, Biophysics, and Structural Biology","Biology","Cell and Developmental Biology","Cell Biology","Life Sciences"],"dc:title":["Characterization and regulation of Skn-directed autoimmune skin lesions"],"thesis:degree_discipline":["Joan C. Edwards School of Medicine"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Biomedical Sciences"]},"updated_at":"2026-11-21T19:57:29Z"}